NCT07487896
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma
- Locations
-
- 144 Anqing, Anhui, China
- 135 Bengbu, Anhui, China
- 133 Hefei, Anhui, China
- 143 Hefei, Anhui, China
Clinical trial condition
Advanced Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Advanced Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
9 public trials
7 recruiting studies
Advanced Esophageal Squamous Cell Carcinoma trial results
NCT06265285
- Conditions
- Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT05910827
- Conditions
- Advanced Cutaneous Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +21 more
- Locations
-
- GenesisCare North Shore Sydney, New South Wales, Australia
- Westmead Hospital Westmead, New South Wales, Australia
- ICON Cancer Centre South Brisbane Brisbane, Queensland, Australia
- Greenslopes Private Hospital Greenslopes, Queensland, Australia
NCT07484724
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma
- Locations
-
- Cancer Hospital of Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT06489197
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma, ESCC
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT05214222
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma
- Locations
-
- Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
NCT06512428
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma
- Locations
-
- Harbin Medical University Cancer Hospital Heilongjiang, Harbin, China
Not Yet Recruiting
Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma.
NCT07469241
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma, Unresectable Esophageal Squamous Cell Carcinoma
- Locations
-
Not specified
Not Yet Recruiting
A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma
NCT07446335
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China